MediClin AG (XTER:MED) EBIT per Share : €0.31 (TTM As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is MediClin AG EBIT per Share?

MediClin AG's EBIT per Share for the three months ended in Dec. 2023 was €-0.34. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.31.

During the past 12 months, the average EBIT per Share Growth Rate of MediClin AG was -10.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for MediClin AG's EBIT per Share or its related term are showing as below:

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of MediClin AG was 153.00% per year. The lowest was -62.00% per year. And the median was -17.90% per year.

XTER:MED's 3-Year EBIT Growth Rate is not ranked ^*
in the Healthcare Providers & Services industry.
Industry Median: 8.6
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

MediClin AG's EBIT for the three months ended in Dec. 2023 was €-16.0 Mil.

MediClin AG EBIT per Share Historical Data

The historical data trend for MediClin AG's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediClin AG EBIT per Share Chart

MediClin AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

0.48

0.01

0.25

0.43

0.32

MediClin AG Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EBIT per Share	Get a 7-Day Free Trial															0.22	-0.03	0.30	0.39	-0.34

MediClin AG EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

MediClin AG's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	15.259	/	47.500
=	0.32

MediClin AG's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-16.024	/	46.807
=	-0.34

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.31

MediClin AG (XTER:MED) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

MediClin AG EBIT per Share Related Terms

Thank you for viewing the detailed overview of MediClin AG's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

MediClin AG (XTER:MED) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MediClin AG (XTER:MED) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

MED:Germany MED:Germany

Address

Okenstrasse 27, Offenburg, DEU, 77652

Website

https://www.mediclin.de

MediClin AG is a company engaged in operating hospitals. It is focused on providing services in the areas of neurosciences and psychological sciences as well as orthopedics in Germany. The hospitals are acute-care hospitals providing basic, standard, and specialized care, as well as specialist clinics for medical rehabilitation. The operating segments of the group are Post-acute, Acute and Other activities. It generates majority of the revenue from the Post-acute segment in which the firm offers services in the fields of subsequent nursing treatment and curative treatment. Subsequent nursing treatment starts after acute care treatment and includes all medical measures required to facilitate the healing process and return the patient to a functioning state.